FDA Drug Application (202743) for AZELASTINE HYDROCHLORIDE by PERRIGO ISRAEL

Back to FDA Applications sponsored by PERRIGO ISRAEL

Application Number202743
Product Number001
FormSPRAY, METERED;NASAL
DosageEQ 0.1876MG BASE/SPRAY
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAZELASTINE HYDROCHLORIDE
Active IngredientAZELASTINE HYDROCHLORIDE



Back to FDA Applications sponsored by PERRIGO ISRAEL

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.